Update of the human parvovirus B19 biology

Transfusion clinique et biologique : journal de la Société française de transfusion sanguine
Annabelle Servant-Delmas, Frédéric Morinet

Abstract

Since its discovery, the human parvovirus B19 (B19V) has been associated with many clinical situations in addition to the prototype clinical manifestations, i.e. erythema infectiosum and erythroblastopenia crisis. The clinical significance of the viral B19V DNA persistence in sera after acute infection remains largely unknown. Such data may constitute a new clinical entity and is discussed in this manuscript. In 2002, despite the genetic diversity among B19V viruses has been reported to be very low, the description of markedly distinct sequences showed a new organization into three genotypes. The most recent common ancestor for B19V genotypes was estimated at early 1800s. B19V replication is enhanced by hypoxia and this might to explain the high viral load detected by quantitative PCR in the sera of infected patients. The minimum infectious dose necessary to transmit B19V infection by the transfusion of labile blood products remains unclear. At the opposite, the US Food and Drug Administration proposed a limit of 10(4)IU/mL of viral DNA in plasma pools used for the production of plasma derivatives. Recently, a new human parvovirus (PARV4) has been discovered. The consequences on blood transfusion of this blood-borne agent and i...Continue Reading

References

Jan 11, 1975·Lancet·Y E CossartD Widdows
Jun 1, 1990·The Journal of Pediatrics·J Saint-MartinF Morinet
Oct 1, 1989·The Journal of Clinical Investigation·G J KurtzmanN S Young
Aug 1, 1987·Journal of Virological Methods·M J Anderson
Mar 1, 1987·Blood Reviews·J R Pattison
Dec 7, 1984·Science·S F Cotmore, P Tattersall
Jul 1, 1995·Annals of the Rheumatic Diseases·S NikkariP Toivanen
Apr 28, 1994·The New England Journal of Medicine·K E BrownN S Young
Oct 1, 1993·Science·K E BrownN S Young
Sep 1, 1993·European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology·P CassinottiG Siegl
Jul 23, 1996·Proceedings of the National Academy of Sciences of the United States of America·P R ChipmanM G Rossmann
Nov 20, 1997·Journal of Medical Virology·P CassinottiG Siegl
Mar 19, 1999·Clinical Transplantation·S MarchandB Charpentier
Nov 13, 2001·Developmental Cell·Z ZádoriP Tijssen
Aug 21, 2002·Journal of Virology·Annabelle ServantAntoine Garbarg-Chenon
Nov 21, 2002·Virology·Kati HokynarKlaus Hedman
May 7, 2004·The New England Journal of Medicine·Burkhard D BültmannKarin Klingel
May 8, 2004·Journal of Clinical Microbiology·Kati HokynarMaria Söderlund-Venermo
Aug 4, 2004·Proceedings of the National Academy of Sciences of the United States of America·Bärbel KaufmannMichael G Rossmann
Aug 26, 2004·Virology·Sylvie PilletFrédéric Morinet
Oct 28, 2004·Journal of Virology·Daniel CandottiJean-Pierre Allain
Jun 7, 2005·Transfusion·Chuan-ging WuMei-ying W Yu
Jun 16, 2005·Journal of Virology·Morris S JonesEric Delwart
Aug 25, 2005·Proceedings of the National Academy of Sciences of the United States of America·Tobias AllanderBjörn Andersson
Dec 1, 2005·Journal of Veterinary Medicine. B, Infectious Diseases and Veterinary Public Health·C-T BockR Kandolf
May 3, 2006·Proceedings of the National Academy of Sciences of the United States of America·Päivi NorjaKlaus Hedman
Aug 31, 2006·Gynecologic and Obstetric Investigation·Marinko DobecFranz Kaeppeli
Sep 12, 2006·The Journal of General Virology·Nguyen L ToanC-Thomas Bock
Oct 17, 2006·The Journal of Infectious Diseases·A ManningP Simmonds
Jan 26, 2007·The Journal of General Virology·Armen ParsyanDaniel Candotti
Sep 21, 2007·Transfusion·Kevin E Brown, Peter Simmonds
Sep 21, 2007·Transfusion·Steven H KleinmanUNKNOWN National Heart, Lung, Blood Institute Retrovirus Epidemiology Donor Study (REDS-II)
May 8, 2008·Journal of Medical Virology·U KühlH-P Schultheiss
May 16, 2009·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Miltiadis DouvoyiannisDavid L Goldman
Aug 19, 2009·Blood·Steven H KleinmanUNKNOWN National Heart, Lung, and Blood Institute Retrovirus Epidemiology Donor Study-II (NHLBI REDS-II)

❮ Previous
Next ❯

Citations

May 26, 2016·Reviews in Endocrine & Metabolic Disorders·Poupak FallahiAlessandro Antonelli
Mar 7, 2019·Journal of Medical Virology·Kerri Lee FrancoisPravi Moodley
Mar 14, 2017·Frontiers in Immunology·J Luis EspinozaShinji Nakao
Apr 5, 2017·Frontiers in Endocrinology·Silvia Martina FerrariSalvatore Benvenga
Dec 31, 2019·BioMed Research International·Sagad Omer Obeid MohamedGehad Abdelmonem Abdalla Ibrahim
Jul 26, 2017·Transplant Infectious Disease : an Official Journal of the Transplantation Society·Chung Hee BaekSu-Kil Park
Aug 8, 2020·Open Forum Infectious Diseases·Kei NishiyamaShouichi Ohga

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.

Related Papers

Transfusion clinique et biologique : journal de la Société française de transfusion sanguine
A Servant-DelmasJ-J Lefrère
Journal of Virology
Annabelle Servant-DelmasSylvie Pillet
Annals of the New York Academy of Sciences
G H WERNERG RAKE
© 2022 Meta ULC. All rights reserved